Cargando…

Trends for in-office usage of pharmacological sedation agents in India: A narrative review

BACKGROUND AND AIMS: Conscious sedation plays a significant role in in-office pharmacological behavior management for short-term procedures in children and apprehensive adults. The advantage conscious sedation provides is by improving quality of care provided by decreasing pain and anxiety while mai...

Descripción completa

Detalles Bibliográficos
Autores principales: Joshi, Sakshi, Gupta, Anil, Garg, Shalini, Dogra, Shikha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191814/
https://www.ncbi.nlm.nih.gov/pubmed/35706640
http://dx.doi.org/10.4103/joacp.JOACP_146_20
_version_ 1784726100543275008
author Joshi, Sakshi
Gupta, Anil
Garg, Shalini
Dogra, Shikha
author_facet Joshi, Sakshi
Gupta, Anil
Garg, Shalini
Dogra, Shikha
author_sort Joshi, Sakshi
collection PubMed
description BACKGROUND AND AIMS: Conscious sedation plays a significant role in in-office pharmacological behavior management for short-term procedures in children and apprehensive adults. The advantage conscious sedation provides is by improving quality of care provided by decreasing pain and anxiety while maintaining a patent airway and adequate spontaneous ventilation. METHODOLOGY: Present review was conducted to evaluate recent trends regarding use of in-office pharmacological sedation agents in India. A rigorous search was conducted through five electronic databases namely PubMed, Scopus, Web of Science, Cochrane Database, and CTRI (Clinical Trial Registry – India). The search period was defined to be last 5 years, that is, from 1(st) January 2014 to 31(st) July 2019. Terminologies “Conscious Sedation,” “In-office Sedation,” “Midazolam,” “Nitrous Oxide,” “India” were included in the search. The Boolean Operation “OR” and “AND” were applied to combine the terminologies. RESULTS: A total of 20 studies were identified following strict inclusion and exclusion criteria. The included studies were evaluated for study design, speciality involved, number of individuals and their age groups, drugs compared along with route and dosage, procedures undertaken, place of study and results. Dental fraternity (13) had more number of trials conducted as compared to medical fraternity (7) in the stimulated period, with South Indian region having maximum trials registered or published. CONCLUSION: Midazolam was observed to the drug of choice for in-office sedation procedures in Indian Scenario. The limitation of study is that the published clinical studies are limited to a few states of India.
format Online
Article
Text
id pubmed-9191814
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-91918142022-06-14 Trends for in-office usage of pharmacological sedation agents in India: A narrative review Joshi, Sakshi Gupta, Anil Garg, Shalini Dogra, Shikha J Anaesthesiol Clin Pharmacol Review Article BACKGROUND AND AIMS: Conscious sedation plays a significant role in in-office pharmacological behavior management for short-term procedures in children and apprehensive adults. The advantage conscious sedation provides is by improving quality of care provided by decreasing pain and anxiety while maintaining a patent airway and adequate spontaneous ventilation. METHODOLOGY: Present review was conducted to evaluate recent trends regarding use of in-office pharmacological sedation agents in India. A rigorous search was conducted through five electronic databases namely PubMed, Scopus, Web of Science, Cochrane Database, and CTRI (Clinical Trial Registry – India). The search period was defined to be last 5 years, that is, from 1(st) January 2014 to 31(st) July 2019. Terminologies “Conscious Sedation,” “In-office Sedation,” “Midazolam,” “Nitrous Oxide,” “India” were included in the search. The Boolean Operation “OR” and “AND” were applied to combine the terminologies. RESULTS: A total of 20 studies were identified following strict inclusion and exclusion criteria. The included studies were evaluated for study design, speciality involved, number of individuals and their age groups, drugs compared along with route and dosage, procedures undertaken, place of study and results. Dental fraternity (13) had more number of trials conducted as compared to medical fraternity (7) in the stimulated period, with South Indian region having maximum trials registered or published. CONCLUSION: Midazolam was observed to the drug of choice for in-office sedation procedures in Indian Scenario. The limitation of study is that the published clinical studies are limited to a few states of India. Wolters Kluwer - Medknow 2022 2021-11-02 /pmc/articles/PMC9191814/ /pubmed/35706640 http://dx.doi.org/10.4103/joacp.JOACP_146_20 Text en Copyright: © 2021 Journal of Anaesthesiology Clinical Pharmacology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Review Article
Joshi, Sakshi
Gupta, Anil
Garg, Shalini
Dogra, Shikha
Trends for in-office usage of pharmacological sedation agents in India: A narrative review
title Trends for in-office usage of pharmacological sedation agents in India: A narrative review
title_full Trends for in-office usage of pharmacological sedation agents in India: A narrative review
title_fullStr Trends for in-office usage of pharmacological sedation agents in India: A narrative review
title_full_unstemmed Trends for in-office usage of pharmacological sedation agents in India: A narrative review
title_short Trends for in-office usage of pharmacological sedation agents in India: A narrative review
title_sort trends for in-office usage of pharmacological sedation agents in india: a narrative review
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191814/
https://www.ncbi.nlm.nih.gov/pubmed/35706640
http://dx.doi.org/10.4103/joacp.JOACP_146_20
work_keys_str_mv AT joshisakshi trendsforinofficeusageofpharmacologicalsedationagentsinindiaanarrativereview
AT guptaanil trendsforinofficeusageofpharmacologicalsedationagentsinindiaanarrativereview
AT gargshalini trendsforinofficeusageofpharmacologicalsedationagentsinindiaanarrativereview
AT dograshikha trendsforinofficeusageofpharmacologicalsedationagentsinindiaanarrativereview